Nasdaq confirms Entero Therapeutics regains compliance with equity rule

GridAI Technologies Corp.

Nasdaq letter dated Oct 28, 2025 confirms company meets $2.5M minimum stockholders' equity requirement.
Company previously reported negative equity of ($3.87M) in 10-K; received extension until Oct 8, 2025.
Compliance achieved via share exchange with GridAI Corp, disclosed in Oct 6, 2025 8-K.
Nasdaq warned that failure to maintain compliance in next periodic report may trigger delisting proceedings.
Company's stock (ENTO) continues trading on Nasdaq Capital Market without immediate delisting risk.

item 8.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001104659-25-104917
form_type: 8-K
ticker: GRDX
cik: 0001604191
company_name: GridAI Technologies Corp.
filed_at: 2025-10-31T23:59:59+00:00
discovered_at: 2026-05-14T18:02:39.895738+00:00
generated_at: 2026-05-17T01:06:48.631220+00:00
sec_items: ["8.01"]
event_type: regulatory
sentiment: positive
materiality_score: 0.55
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001104659-25-104917
json_url: https://secwatch.observer/filing/0001104659-25-104917.json
markdown_url: https://secwatch.observer/filing/0001104659-25-104917.md
text_url: https://secwatch.observer/filing/0001104659-25-104917.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1604191/000110465925104917/0001104659-25-104917-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1604191/000110465925104917/tm2529898d1_8k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0001104659-25-104917

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.